CIBC Private Wealth Group’s Avadel Pharmaceuticals AVDL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,253
| Closed | -$516K | – | 3095 |
|
|
2025
Q1 | $516K | Hold |
78,253
| – | – | ﹤0.01% | 798 |
|
|
2024
Q4 | $837K | Hold |
78,253
| – | – | ﹤0.01% | 737 |
|
|
2024
Q3 | $1.03M | Buy |
+78,253
| New | +$1.03M | ﹤0.01% | 684 |
|
|
2024
Q2 | – | Sell |
-58,934
| Closed | -$982K | – | 3156 |
|
|
2024
Q1 | $982K | Sell |
58,934
-4,695
| -7% | -$78.2K | ﹤0.01% | 679 |
|
|
2023
Q4 | $898K | Sell |
63,629
-29,799
| -32% | -$421K | ﹤0.01% | 657 |
|
|
2023
Q3 | $962K | Sell |
93,428
-82
| -0.1% | -$845 | ﹤0.01% | 614 |
|
|
2023
Q2 | $1.54M | Sell |
93,510
-49,575
| -35% | -$817K | ﹤0.01% | 530 |
|
|
2023
Q1 | $1.31M | Buy |
143,085
+4,080
| +3% | +$37.4K | ﹤0.01% | 570 |
|
|
2022
Q4 | $995K | Sell |
139,005
-20,000
| -13% | -$143K | ﹤0.01% | 531 |
|
|
2022
Q3 | $797K | Sell |
159,005
-6,000
| -4% | -$30.1K | ﹤0.01% | 635 |
|
|
2022
Q2 | $403K | Buy |
165,005
+58,934
| +56% | +$144K | ﹤0.01% | 744 |
|
|
2022
Q1 | $724K | Sell |
106,071
-59,284
| -36% | -$405K | ﹤0.01% | 686 |
|
|
2021
Q4 | $1.34M | Hold |
165,355
| – | – | ﹤0.01% | 592 |
|
|
2021
Q3 | $1.62M | Hold |
165,355
| – | – | ﹤0.01% | 537 |
|
|
2021
Q2 | $1.11M | Hold |
165,355
| – | – | ﹤0.01% | 639 |
|
|
2021
Q1 | $1.5M | Buy |
165,355
+100,350
| +154% | +$907K | ﹤0.01% | 593 |
|
|
2020
Q4 | $434K | Hold |
65,005
| – | – | ﹤0.01% | 797 |
|
|
2020
Q3 | $328K | Buy |
+65,005
| New | +$328K | ﹤0.01% | 765 |
|
|
2020
Q1 | – | Sell |
-150,000
| Closed | -$1.13M | – | 842 |
|
|
2019
Q4 | $1.13M | Hold |
150,000
| – | – | ﹤0.01% | 556 |
|
|
2019
Q3 | $624K | Hold |
150,000
| – | – | ﹤0.01% | 654 |
|
|
2019
Q2 | $434K | Buy |
+150,000
| New | +$434K | ﹤0.01% | 737 |
|